IMAGINAB, INC.

Profile

Company Names

IMAGINAB, INC.

Addresses

440 HINDRY AVENUE, SUITE D, INGLEWOOD, CA 90301

423 HINDRY AVENUE, SUITE D, INGLEWOOD, CA 90301

440 HINDRY AVENUE, SUITE E, INGLEWOOD, CA 90301

Phone Numbers

(310) 645-1211
310-258-2411

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$35,826,058.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2017-09-05 
$7,672,316.00 
$12,000,000.00 
$4,327,684.00 
Equity 
3
2016-03-31 
$5,341,245.00 
$9,500,000.00 
$4,158,755.00 
Equity 
2
2014-05-07 
$15,562,497.00 
$20,749,995.00 
$5,187,498.00 
Equity 
1
2012-03-23 
$7,250,000.00 
$12,500,000.00 
$5,250,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFF 
 
BAILEY 
DIRECTOR
BEO BANCORP   |  IMAGINAB, INC.   |  BSC CAPITAL PARTNERS FUND I, L.P.
CHRISTIAN 
 
BEHRENBRUCH 
EXECUTIVE OFFICER, DIRECTOR
IMAGINAB, INC.
ISAAC 
 
BRIGHT 
DIRECTOR
QUANTALIFE INC   |  IMAGINAB, INC.
VALERIE 
 
CALENDA 
DIRECTOR
NEUROPHAGE PHARMACEUTICALS INC   |  IMAGINAB, INC.
ABBIE 
 
CELNIKER 
DIRECTOR
TALIGEN THERAPEUTICS INC   |  IMAGINAB, INC.   |  THIRD ROCK VENTURES IV, L.P.   |  GOLDFINCH BIOPHARMA, INC.   |  RHEOS MEDICINES, INC.   |  PANOPTICA, INC.   |  THIRD ROCK VENTURES V, L.P.   |  GOLDFINCH BIO, INC.   |  CEDILLA THERAPEUTICS, INC.   |  ABATA THERAPEUTICS, INC.   |  THIRD ROCK VENTURES VI, L.P.
BENJAMIN 
 
CHEN 
EXECUTIVE OFFICER
MOCHILA INC   |  ARKAMI, INC.   |  IMAGINAB, INC.   |  CARBITEX, INC.   |  ONCXERNA THERAPEUTICS, LTD.   |  HC BIOSCIENCE, INC.   |  ACTYM THERAPEUTICS, INC.
MARTYN 
 
COOMBS 
EXECUTIVE OFFICER, DIRECTOR
IMAGINAB, INC.
RICHARD 
 
DING 
DIRECTOR
QUANTALIFE INC   |  IMAGINAB, INC.
K. 
LEONARD 
JUDSON 
DIRECTOR
SOFIE BIOSCIENCES, INC.   |  IMAGINAB, INC.   |  LIXIVIA, INC.   |  FORMETRIX, INC.
JENNIFER 
 
KEPPLER 
EXECUTIVE OFFICER
IMAGINAB, INC.
JOSEPH 
 
LIMBER 
DIRECTOR
IMAGINAB, INC.   |  SECURA BIO HOLDINGS, INC.   |  SECURA BIO, INC.
CAMPBELL 
 
MURRAY 
DIRECTOR
ALIOS BIOPHARMA INC   |  TOKAI PHARMACEUTICALS INC   |  AILERON THERAPEUTICS INC   |  BIORELIX INC   |  EUTHYMICS BIOSCIENCE INC   |  AKEBIA THERAPEUTICS, INC.   |  AERPIO THERAPEUTICS, INC.   |  NEUROVANCE, INC.   |  EBI LIFE SCIENCES, INC.   |  IMAGINAB, INC.   |  GALERA THERAPEUTICS, INC.   |  BIONANO GENOMICS, INC   |  EUTHYMICS BIOSCIENCE, INC.   |  ICEBREAKER HEALTH, INC.   |  ANNEXON, INC.   |  TSCAN THERAPEUTICS, INC.   |  RENOVACOR, INC.   |  LIGHTHOUSE PHARMACEUTICALS, INC.
JEFFREY 
D. 
QUAN 
EXECUTIVE OFFICER
IMAGINAB, INC.
THILO 
 
SCHROEDER 
DIRECTOR
BLUEPRINT MEDICINES CORP   |  IMAGINAB, INC.   |  IDEAYA BIOSCIENCES, INC.   |  REVOLUTION MEDICINES, INC.   |  SILVERBACK THERAPEUTICS, INC.   |  CIRCLE PHARMA, INC.   |  ALTEROME THERAPEUTICS, INC.   |  NEXTECH VII ONCOLOGY SCSP   |  NEXTECH CROSSOVER I SCSP   |  NEXTECH VII CARRY SCSP   |  NEXTECH CROSSOVER I CARRY SCSP   |  NEXTECH VIII SCSP   |  STIPPLE BIO, INC.
ANNA 
W. 
WORK 
DIRECTOR
IMAGINAB, INC.
ANNA 
M. 
WU 
EXECUTIVE OFFICER, DIRECTOR
IMAGINAB, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-09-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-05 
2016-04-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-31 
2014-07-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-07 
2012-04-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#